Charité Entrepreneurship Summit 2012


Since its successful launch in 2007, the Charité Entrepreneurship Summit has become an international forum for participants and speakers from medicine, the life sciences, entrepreneurship, venture capital, tech transfer, and related fields.

On April 23-24, 2012, Stiftung Charité, Kauffman Foundation, and Charité Medical School hosted the fifth “Charité Entrepreneurship Summit” at Humboldt Carré in Berlin. Once again researchers, clinicians, and doctoral students presented fresh ideas and learned from successful entrepreneurs, investors, and business developers.

Doctoral students, postdocs, and resident physicians were able to register for free while space was available. All other members of universities or research institutes as well as start-up teams, tech transfer professionals, and clinicians at non-academic hospitals, benefited from substantial discounts.

If you have any further questions, please contact us by telephone +49 30 450570-509 or send us an email.

See some of our confirmed Speakers below, or take a look at all confirmed speakers.

    Edward S. Andrle

    Ed is Vice President of Business Development and Strategy at the Sorin Group. He is also a director at MD Start SA in Lausanne/ Switzerland. Prior to Sorin, Mr. Andrle co-founded, developed, and sold three medical device companies in the Minneapolis area.

    Michael Brehm

    Michael is managing director at Rebate Networks GmbH and investor in Daily Deal GmbH as well as other companies. Earlier, he co-founded StudiVZ group, now one of the largest internet based social networks with approx. 15 Mio users.
     

    Anne Glover

    Anne is a co-founder and chief executive of Amadeus Capital Partners Ltd., the management company that provides investment services to the Amadeus venture capital funds.

    Simon E. Moroney

    Simon is a co-founder of MorphoSys, one of the most successful biotech companies in Germany, and its CEO.

    Alexander Osterwalder

    Alexander works as an independent author, speaker, and advisor with a focus on business model innovation, strategic management, and management innovation. His book “Business Model Generation” is an international bestseller.

    Martin Rothman

    Martin is a world-renowned interventional cardiologist and Vice President, Medical Affairs for Coronary and Peripheral Vascular Business, at Medtronic. Previously he worked for the UK National Health Service for almost 40 years, including a decade spent as director of cardiac research and development at the London Chest Hospital.

    Stephan Schambach

    Stephan is a true visionary among German entrepreneurs: Among the first to recognize the potential of the e-commerce industry, he independently invented some of today's essential industry standards. He is the Founder and Chairman of Demandware. Previously, he founded Intershop Communications AG, one of the  first software start-ups in East Germany after the Berlin Wall came down, and led it to its successful NASDAQ listing.

    Halle Tecco

    Halle directs Rock Health, the first seed-accelerator for health apps. She works directly with startups, helping them develop sustainable business models and connecting them with strategic partners.

    Sander van Deventer

    Sander is general partner at the Dutch venture capital firm Forbion Capital Partners. He is also professor of translational gastroenterology at Leiden University Medical Center and has extensive experience in translational research with particular emphasis on drug development.

    Stefan Vilsmeier

    Stefan is one of the leading medical device entrepreneurs in Germany. He founded Brainlab in 1989 and spearheaded new developments in neuro-navigation and radiotherapy. Today Brainlab AG is a global corporation that employs 1,000 people worldwide, generating more than 50 percent of its revenues in the US, and has partnerships with leading healthcare companies. In December 2002, the World Economic Forum (WEF) selected Stefan Vilsmeier as one of their 'Global Leaders for Tomorrow 2003'.

    Bernd Wegener

    Bernd Wegener, a veterinarian, founded and led B.R.A.H.M.S Diagnostica for many years, starting with a management buyout and ending with a successful sale to Thermo Fisher Scientific in 2009. Before that, he was active in various leading and directing roles at Boehringer Ingelheim KG, the Degussa pharmacology group, Marion Merrell Dow GmbH, and Henning Berlin GmbH. He is an active investor and serves on several boards.

    Chuck Wilson

    Chuck serves as the Global Head of Strategic Alliances at the Novartis Institutes for BioMedical Research, leading a group responsible for research partnering at Novartis. Partnering efforts include academic relationships to understand disease processes, biotech collaborations to access drug discovery technologies, and in-licensing of compounds prior to clinical proof-of-concept.